Discovery Research Articles
-
ADCs: From Design To Development
1/4/2024
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
Utilizing MAPPs For An Enhanced Assessment Of Immunogenicity
1/4/2024
Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.
-
Considerations And Strategies For Hiring Biopharma Consultants
12/8/2023
Most organizations do not have the budget or workload to justify a team spanning all possible subspecialties. So, those gaps typically are filled with consultants who add clear value to delivering products and services for the company’s clients. But how do you find the right consultants?
-
Live Biotherapeutics And Next Gen Manufacturing
10/5/2023
With services to develop and scale up Probiotics, Postbiotics and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.
-
Recommendations For Successful IND Approval Of RNA-LNP Drugs
8/22/2023
The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.
-
De-Risking Preclinical Candidates With Predictive Immunotoxicology
8/14/2023
From target engagement and mechanism of action to efficacy and prediction of adverse immune reactions, immunology assays deliver data that reduce your risk of failing later.
-
Developing Assays For Insulin Analogs And Other Large Peptides
7/14/2023
Learn how a physicochemical-based approach can help to accelerate the development of bioanalytical assays for insulin analogs, avoiding delays and increasing efficiency in clinical trial processes.
-
Safety Pharmacology
6/20/2023
A partner with the expertise to guide your project through regulatory constraints and provide meaningful data to drive decision making is essential for meeting milestones and accelerating to commercialization.
-
Nonrodent Models: Minipig Specialty Capabilities
6/1/2023
The minipig's similarity to humans, availability, known disease status, and feasibility of genetic manipulation offer advantages over traditional species, impacting ethical considerations and cost of animals in biomedical research.
-
Bioengineering Solutions Using A Fully Integrated Ecosystem
5/30/2023
Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.